SevenBridge Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-514
| Closed | -$226K | – | 229 |
|
|
2025
Q1 | $226K | Sell |
514
-485
| -49% | -$213K | 0.04% | 206 |
|
|
2024
Q4 | $455K | Hold |
999
| – | – | 0.09% | 151 |
|
|
2024
Q3 | $501K | Hold |
999
| – | – | 0.1% | 145 |
|
|
2024
Q2 | $474K | Hold |
999
| – | – | 0.1% | 138 |
|
|
2024
Q1 | $401K | Sell |
999
-335
| -25% | -$134K | 0.09% | 146 |
|
|
2023
Q4 | $543K | Buy |
1,334
+175
| +15% | +$71.2K | 0.13% | 125 |
|
|
2023
Q3 | $403K | Hold |
1,159
| – | – | 0.1% | 134 |
|
|
2023
Q2 | $408K | Sell |
1,159
-150
| -11% | -$52.8K | 0.11% | 132 |
|
|
2023
Q1 | $412K | Sell |
1,309
-35
| -3% | -$11K | 0.11% | 131 |
|
|
2022
Q4 | $388K | Sell |
1,344
-16
| -1% | -$4.62K | 0.11% | 133 |
|
|
2022
Q3 | $394K | Hold |
1,360
| – | – | 0.13% | 119 |
|
|
2022
Q2 | $383K | Sell |
1,360
-90
| -6% | -$25.3K | 0.15% | 101 |
|
|
2022
Q1 | $378K | Sell |
1,450
-210
| -13% | -$54.7K | 0.13% | 112 |
|
|
2021
Q4 | $365K | Sell |
1,660
-239
| -13% | -$52.6K | 0.11% | 128 |
|
|
2021
Q3 | $344K | Sell |
1,899
-436
| -19% | -$79K | 0.11% | 124 |
|
|
2021
Q2 | $471K | Buy |
2,335
+82
| +4% | +$16.5K | 0.15% | 112 |
|
|
2021
Q1 | $484K | Buy |
2,253
+565
| +33% | +$121K | 0.18% | 104 |
|
|
2020
Q4 | $399K | Buy |
+1,688
| New | +$399K | 0.16% | 106 |
|
|
2020
Q3 | – | Sell |
-1,336
| Closed | -$388K | – | 141 |
|
|
2020
Q2 | $388K | Hold |
1,336
| – | – | 0.19% | 96 |
|
|
2020
Q1 | $318K | Hold |
1,336
| – | – | 0.18% | 96 |
|
|
2019
Q4 | $293K | Hold |
1,336
| – | – | 0.08% | 114 |
|
|
2019
Q3 | $226K | Buy |
+1,336
| New | +$226K | 0.12% | 128 |
|